| | | | | | | | | Sponsored | | Support earlier, more connected cardiometabolic insight with Siemens Healthineers. Includes the first and only prognostic high-sensitivity troponin I assay available in the U.S. and the first and only blood test authorized for use as a prognostic marker in patients with advanced fibrosis due to MASH. Enable a more complete testing approach without added complexity. |
|
|
| | |
| |
| | |
|
|
| | | | | | MLO invites clinical laboratory professionals to participate in a quick survey on molecular diagnostics, with results to be featured in the upcoming November issue, offering valuable industry insights. |
|
|
|
| |
| | |
|
|
| | | | | | Salin Sriudomporn and Bryan Patenaude of Johns Hopkins have published a literature review in Vaccine, revealing the financial burden of measles in the U.S. |
|
|
|
| |
| | |
|
|
| | | | | | The College of American Pathologists (CAP) is advocating for clinical laboratories to prepare now for the United States to lose its measles elimination status. This could happen in November, according to a May Lancet article. |
|
|
|
| |
| | |
|
|
| | | | | | To expand medical laboratory testing in Southern Nevada, the Nevada Health and Bioscience Corp. (NHBC) with University Medical Center, the City of Las Vegas, and the State of Nevada are opening the NHBC Academic Laboratory in early 2027, according to a Las Vegas Sun article by Grace Da Rocha. |
|
|
|
| |
| | |
|
|
| | | | | | Stay connected with MLO on YouTube! Explore expert insights, laboratory management strategies, data analytics, technology, and industry perspectives—all in one place. Subscribe to @MLO-online for the latest videos from Medical Laboratory Observer. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
